Discovery of a Novel Microbial Glycoside Hydrolase Directing Formation of New α‐Amylase Inhibitors
Chemistry – A European Journal · 16.06.2026 · 32 (23)
DOI: 10.1002/chem.202600033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 07.04.2026. Verfasst von Tong Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioact…. Hauptthemen laut MEDLINE: alpha-Amylases, Oligosaccharides, Glycoside Hydrolases, Streptomyces. Die Arbeit nennt 40 Literaturangaben. Gefördert von: the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Glycoside hydrolases (GHs) comprise a large and diverse family of enzymes that catalyze the hydrolysis of glycosidic bonds in a wide range of glycan substrates, including polysaccharides, oligosaccharides, and glycoconjugates. In addition to their fundamental roles in biological systems, GHs are widely exploited in industrial and biomedical applications. Here, we report the identification and functional characterization of a new GH, Acm11, from the biosynthetic gene cluster of pseudo ‐oligosaccharide acarviostatin I03 in a streptomyce strain. Bioinformatic analysis predicts Acm11 to be an α‐amylase containing a C‐terminal starch‐binding domain. Disruption of the acm11 resulted in decrease of acarviostatin I03 production. Consistently, in vitro enzymatic assays demonstrated that Acm11 efficiently hydrolyzes starch, indicating its involvement in acarviostatin I03 biosynthesis. Notably, Acm11 also exhibited hydrolytic activity toward oligosaccharide substrates, progressively removing glucose units from acarviostatin I03 and acarbose. In addition to hydrolysis, Acm11 catalyzed C7‐cyclitol‐(1→4)‐glycosylation of acarviostatin I03 and acarbose in the presence of maltooligosaccharides, revealing an unexpected transglycosylation activity. Mutational analysis indicated that distinct amino acid residues are responsible for hydrolytic and transglycosylation activities and evolution of Acm11 is expected to yield variants with altered catalytic preferences as the promising biocatalysts to generate structurally diverse and functionally improved α‐amylase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAMS Key Laboratory of Synthetic Biology For Drug Innovation, NHC Key Laboratory of Biotechnology for Microbial Drugs, State Key Laboratory of Bioactive Substance & Function of Natural Medicines, Institute of Medicinal…
ORCID-Profile: Tong Zou, Zefang Miao, Yulin Yao, Ruofei Li
Förderung
- the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
Zitieren
APA
Zou, T., Miao, Z., Yao, Y., Li, R., & He, H. Y. (2026). Discovery of a Novel Microbial Glycoside Hydrolase Directing Formation of New α‐Amylase Inhibitors. Chemistry – A European Journal, 32(23). https://doi.org/10.1002/chem.202600033
Vancouver
Zou T, Miao Z, Yao Y, Li R, He HY. Discovery of a Novel Microbial Glycoside Hydrolase Directing Formation of New α‐Amylase Inhibitors. Chemistry – A European Journal. 2026;32(23). doi:10.1002/chem.202600033
BibTeX
@article{Zou2026,
author = {Zou, Tong and Miao, Zefang and Yao, Yulin and Li, Ruofei and He, Hai-Yan},
title = {Discovery of a Novel Microbial Glycoside Hydrolase Directing Formation of New α‐Amylase Inhibitors},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {23},
doi = {10.1002/chem.202600033}
}
EUVIMED